Cryo-Cell net income jumps 70% to $1.27 million in fiscal Q3; revenue flat at $7.82 million
CCEL•Cryo-Cell reported fiscal Q3 2026 net income of $1.27 million, up 70% year over year, while revenue was nearly unchanged at $7.82 million.
1. Quarterly results
Basic and diluted earnings per share rose to $0.16 from $0.09 in the year-ago quarter. Revenue slipped to $7.82 million from $7.83 million. The company said it stores more than 250,000 cord blood and cord tissue specimens through its global affiliates.
